Michael F. Kanan

This profile gathers the share dealings of Michael F. Kanan across 2 companies, led by Sigma Aldrich Corp and Avadel Pharmaceuticals PLC. The record holds 37 filings, for trades running from 15 January 2010 to 7 March 2019.

The open-market side counts 6 purchases for €63k alongside 3 sales for €1.3M. Taken together, the sales exceed the purchases by €1.2M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 16 share grants and 7 option exercises.

Half of the purchases are above €11k and half below.

Most recently, on 11 March 2019, the filings show a share grant in Avadel Pharmaceuticals PLC. The last insider purchase was made public on 29 June 2018, 3,039 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.